Workflow
Nasdaq(NDAQ)
icon
Search documents
Intelligent Living Application Group Inc. Regains Compliance with Nasdaq's Minimum Bid Price Rule
Prnewswire· 2024-09-16 13:00
HONG KONG, Sept. 16, 2024 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ: ILAG) ("Intelligent Living" or the "Company"), a premium lockset manufacturer in Hong Kong, announced today that it has regained compliance with the $1 minimum bid price requirement under the continued listing requirements of the Nasdaq Stock Market LLC ("Nasdaq").On September 13, 2024, the Company received a written notification from Nasdaq's Listing Qualifications Department stating that the closing bid price of t ...
ECD Regains Compliance with Nasdaq Continued Listing Requirement
GlobeNewswire News Room· 2024-09-16 11:30
KISSIMMEE, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq:ECDA) (“ECD” or the “Company”), an industry leader in delivering restored, modified and electrified Land Rover Defenders, Jaguars, and other classic and collectible automobiles announced today that it received a letter from The Nasdaq Stock Market ("Nasdaq") stating that Nasdaq has approved ECD’s application to list its shares of common stock for trading on the Nasdaq Capital Market effective September 13, 2024. As previ ...
S&P 500, Nasdaq Record Best Week Of Year As Alphabet, Super Micro Surge: Fear & Greed Index Moves To 'Neutral' Zone
Benzinga· 2024-09-16 07:47
The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Friday.U.S. stocks settled higher on Friday, with the S&P 500 and the Nasdaq Composite recording their best week of the year. Both indices also notched gains for the fifth straight day. On a weekly basis, the S&P 500 gained 4%, while the Nasdaq added 5.9%. The Dow has climbed 2.6% last week.Shares of Alphabet Inc. GOOGL GOOG gained 1.8%, while Super Micro Computer, Inc. SM ...
Leveraged Exposure To The Nasdaq 100 Via TQQQ: Is It Worth The Risk?
Seeking Alpha· 2024-09-14 09:09
"Give me a lever long enough [...] and I shall move the world." (Archimedes) PM Images Thesis: TQQQ's leverage can be a double-edged sword The ProShares UltraPro QQQ ETF (NASDAQ:TQQQ) offers investors the ability to gain triple the daily returns of the Nasdaq 100 Index. While this can lead to impressive short-term profits in case of a bull market, I believe it also introduces significant risks that need to be carefully managed. In my view, TQQQ is best utilized as a tactical investment for short-term trad ...
Nasdaq Correction: 1 No-Brainer Stock to Buy On This Dip
The Motley Fool· 2024-09-13 21:30
Investors keep underrating this technology giant.We have hit another late summer stock market correction. After going on a monster run in 2023 and early 2024, the Nasdaq 100 technology growth index recently went through a price drop correction. It is currently off 9% from all-time highs hit in early July.One stock down more than twice the Nasdaq 100 index is Alphabet (GOOG 1.82%) (GOOGL 1.79%). The technology giant and parent of Google Search, YouTube, and Google Cloud is down over 20% in just a few months. ...
NorthView Acquisition Corporation Announces Exception Granted by Nasdaq to Permit to The Company to Regain Compliance with Listing Rules
GlobeNewswire News Room· 2024-09-13 20:30
New York, NY, Sept. 13, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an exception to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). Pursuant to the terms of the exception, the Company must file ...
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire News Room· 2024-09-13 12:45
- New CFO Brings Multiple Years of Experience from Biotech Companies- As Part of the New Hire, the Company Issues Inducement Grants Boston (September 13, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the appointment of Alex Epshinsky as the Company’s new Chief Financial Officer (CFO), and that the Company has granted equity awards on September 12, 2024 as a mat ...
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire News Room· 2024-09-13 12:00
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase an aggregate of 3,500 shares of the Company’s stock (the “Inducement Grant”) to a newly hired employee on Sep ...
New Nasdaq-100 Dividend Payer: Is This the Perfect Dividend Growth Stock?
The Motley Fool· 2024-09-13 11:44
Alphabet can now provide investors with both income and growth.One of the world's largest technology growth stocks has finally begun to return cash directly to shareholders. That's right, after piling up cash on its balance sheet for years, Alphabet (GOOG 2.23%) is now paying a small quarterly dividend. So rejoice, income-focused investors: Another high-quality technology company has become an option for your portfolios. But don't think the owner of Google Search and YouTube is done growing. Alphabet now lo ...
Nasdaq Index Today: Nvidia Powers Tech Rally as Upcoming Fed Meeting Sparks Rate Cut Hopes
FX Empire· 2024-09-12 13:14
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...